Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2023-28323
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
A deserialization of untrusted data exists in EPM 2022 Su3 and all prior versions that allows an unauthenticated user to elevate rights. This exploit could potentially be used in conjunction with other OS (Operating System) vulnerabilities to escalate privileges on the machine or be used as a stepping stone to get to other network attached machines.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Ivanti Endpoint Manager 代码问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Ivanti Endpoint Manager(EPM)是美国Ivanti公司的一套端点安全管理器。 Ivanti Endpoint Manager 2022 Su3 存在安全漏洞,该漏洞源于不受信任数据的反序列化,允许未经身份验证的用户提升权限。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IvantiIvanti Endpoint Manager 2022 ~ 2022 -
II. Public POCs for CVE-2023-28323
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2023-28323
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2023-28323

No comments yet


Leave a comment